— Know what they know.
Not Investment Advice

PKTX OTC

ProtoKinetix, Incorporated
1W: +0.0% 1M: -0.0% 3M: -96.2% YTD: -96.9% 1Y: -96.4% 3Y: -99.3% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 46 · $78316 mcap · 244M float · 0.039% daily turnover · Short 66% of daily vol

Cash Flow Trends

Operating Cash Flow
-$223K +40.7% ▲
Capital Expenditures
$58K +1.9% ▲
5Y CAGR: +18.3%
Free Cash Flow
-$223K +48.7% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$25K -388.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$8M-$2M-$2M-$415K-$364K
Depreciation & Amort.$3K$3K$58K$48K$53K
Stock-Based Comp.$7M$1M$1M$0$5K
Change in Working Capital$19K$23K-$27K-$9K$83K
Other Non-Cash Items$7M$1M$1M-$1$0
Operating Cash Flow-$881K-$890K-$805K-$376K-$223K
— Investing Activities —
Capital Expenditures-$70K-$91K-$132K-$59K-$58K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$70-$91-$132$0$0
Investing Cash Flow-$70K-$91K-$132K-$59K-$58K
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow$768K$845K$905K$430K$256K
Net Change in Cash-$184K-$136K-$32K-$5K-$25K
Cash End of Period$193K$58K$26K$20K-$5K
Free Cash Flow-$951K-$981K-$937K-$435K-$223K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms